Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Immune and inflammation

Gastro-intestinal

Modifiable Lifestyle Factors

Diet

Text Availability

Abstract

131

Full text

Free full text

Publication Types

Journal Article

130

Research Support, Non-U.S. Gov't

Review

Randomized Controlled Trial

Research Support, N.I.H., Extramural

Clinical Trial

Observational Study

Comparative Study

Meta-Analysis

Systematic Review

Research Support, N.I.H., Intramural

Multicenter Study

Controlled Clinical Trial

Case Reports

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase III

Research Support, U.S. Gov't, Non-P.H.S.

Clinical Trial, Phase II

Letter

Clinical Trial, Phase I

Clinical Trial Protocol

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Interleukin-18""[mesh_terms]

131 Results

Searching titles within these results

Differentiation of human SH-SY5Y neuroblastoma cells by all-trans retinoic acid activates the interleukin-18 system.

Hannes Sallmon, Victoria Hoene, Sven C Weber, Christof Dame

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2010;30(2):55-8

Full Text

Abstract

Inflammasomes in Clinical Practice: A Brief Introduction.

Mario D Cordero, Beatriz Castejón-Vega, Elísabet Alcocer-Gómez, Macarena López-Sánchez

Experientia supplementum (2012) 2019;108():1-8

Full Text

Abstract

Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.

Reena Agrawal-Rajput, Bhaskar Saha, Naveen Challagundla

Immunologic research 2022;70(5):578-606

Full Text

Abstract

An overview of the involvement of interleukin-18 in degenerative retinopathies.

Matthew Campbell, Sarah L Doyle, Ema Ozaki, Paul F Kenna, Anna-Sophia Kiang, Marian M Humphries, Peter Humphries

Advances in experimental medicine and biology 2014;801():409-15

Full Text

Abstract

Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis.

Yanfei Wei, Yachen Xu, Deyan Jiao, Yuzhen Wang, Rong Xiao, Renhui Sun, Siyu Tan, Tixiao Wang, Xiaowei Guo, Wenwen Yang, Panpan Tian, Zhuanchang Wu, Xiaohong Liang, Chunhong Ma, Lifen Gao, Chunyang Li

Nature communications 2023;14(1):1710

Free Full Text

Abstract

Generation of highly stable IL-18 based on a ligand-receptor complex structure.

Yutaka Yamamoto, Zenichiro Kato, Eiji Matsukuma, Ailian Li, Kentaro Omoya, Kazuyuki Hashimoto, Hidenori Ohnishi, Naomi Kondo

Biochemical and biophysical research communications 2004;317(1):181-6

Full Text

Abstract

Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis.

Paul M Ridker, Jean G MacFadyen, Tom Thuren, Peter Libby

European heart journal 2021;41(23):2153-2163

Full Text

Abstract

Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Arkaitz Mucientes, Antonio Fernández-Nebro, Laura Cano-García, Begoña Oliver-Martos, Fernando Ortiz-Márquez, Aimara Garcia-Studer, Patricia Ruiz-Limón, José Rioja, Sara Manrique-Arija, Rocío Redondo-Rodriguez, Jose Manuel Lisbona-Montañez, Francisco Javier Godoy-Navarrete, Natalia Mena-Vázquez

International journal of molecular sciences 2023;24(7):6800

Free Full Text

Abstract

A natural goldmine of binding proteins and soluble receptors simplified their translation to blockbuster drugs, all in one decade.

Daniela Novick

Frontiers in immunology 2023;14():1151620

Free Full Text

Abstract

The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways.

Shasha Zheng, Matija Hedl, Clara Abraham

Journal of immunology (Baltimore, Md. : 1950) 2014;192(12):5924-32

Free Full Text

Abstract

The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis.

Carol M Artlett

Biomolecules 2022;12(5):634

Free Full Text

Abstract

The role of the NLRP3 inflammasome in atherosclerotic disease: Systematic review and meta-analysis.

Mark Khair, Marina Khair, Venkat N Vangaveti, Usman H Malabu

Journal of cardiology 2024;84(1):14-21

Free Full Text

Abstract

Bariatric surgery and renal function: a precarious balance between benefit and harm.

Christopher D Byrne, Mohamed H Ahmed

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2011;25(10):3142-7

Full Text

Abstract

The Molecular Mechanism of CoenzymeQ10 on Pyroptosis and its Related Diseases: A Review.

Xian-Hui Li, Chuan-Jun Fu, Qiong Xiang

Protein and peptide letters 2022;29(11):911-916

Full Text

Abstract

Pitavastatin reduces elevated IL-18 levels in Japanese subjects with hypercholesterolemia: sub-analysis of Kansai investigation of statin for hyperlipidemic intervention in metabolism and endocrinology (KISHIMEN).

Yoshio Fujioka, Akira Fukuda, Tatsuro Ishida, Shinji Kagimoto, Yoshio Nakamura, Akane Iwakura, Kyoko Hara, Taizo Yamamoto, Akira Kuroe, Michihiro Ohya, Shinpei Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Hiroki Ikeda, Koichiro Nabe, Kinsuke Tsuda, Ataru Taniguchi, Kiyoshi Tanaka, Hiroyuki Koshiyama, Noriaki Kume, Ken-ichi Hirata

Journal of atherosclerosis and thrombosis 2011;18(1):8-15

Free Full Text

Abstract

Results: 1 – 15 / 131

Filters

Expert Opinion

Clinical Imbalances

Modifiable Lifestyle Factors

Text Availability

Publication Types

Publication Year

Results for ""Interleukin-18""[mesh_terms]

Differentiation of human SH-SY5Y neuroblastoma cells by all-trans retinoic acid activates the interleukin-18 system.

Inflammasomes in Clinical Practice: A Brief Introduction.

Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.

An overview of the involvement of interleukin-18 in degenerative retinopathies.

Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis.

Generation of highly stable IL-18 based on a ligand-receptor complex structure.

Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis.

Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease.

A natural goldmine of binding proteins and soluble receptors simplified their translation to blockbuster drugs, all in one decade.

The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways.

The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis.

The role of the NLRP3 inflammasome in atherosclerotic disease: Systematic review and meta-analysis.

Bariatric surgery and renal function: a precarious balance between benefit and harm.

The Molecular Mechanism of CoenzymeQ10 on Pyroptosis and its Related Diseases: A Review.

Pitavastatin reduces elevated IL-18 levels in Japanese subjects with hypercholesterolemia: sub-analysis of Kansai investigation of statin for hyperlipidemic intervention in metabolism and endocrinology (KISHIMEN).

Results for
""Interleukin-18""[mesh_terms]